Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H25NO |
Molecular Weight | 295.4186 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(CCN1CCCCC1)(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=RQXCLMGKHJWMOA-UHFFFAOYSA-N
InChI=1S/C20H25NO/c22-20(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21/h1-2,4-7,10-13,22H,3,8-9,14-17H2
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Development and validation of a dissolution test for meloxicam and pridinol mesylate from combined tablet formulation. | 2010 Mar |
|
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. | 2011 Jul 14 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ndrugs.com/?s=pridinol
Oral Muscle spasms Adult: As mesilate: Usual initial: 2-8 mg tid; Maintenance: 4-8 mg daily.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QM03BX03
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
||
|
WHO-ATC |
M03BX03
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
||
|
NCI_THESAURUS |
C29710
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C73319
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
1320
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
4904
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
511-45-5
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
23016
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
34479
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | RxNorm | ||
|
208-128-0
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
CHEMBL404215
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
9E75Q6SUUB
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
100000081633
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
m9129
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | Merck Index | ||
|
75247
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
PRIDINOL
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
C009185
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
DTXSID0045090
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
2263
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
SUB10037MIG
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
DB13642
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY | |||
|
2684
Created by
admin on Fri Dec 15 16:11:24 GMT 2023 , Edited by admin on Fri Dec 15 16:11:24 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)